Workit Health, a telemedicine startup offering digital evidence-based substance use disorder treatment, including medication for opioid and alcohol use disorders through the web or mobile apps, announced a $12 million round of investment led by FirstMark Capital.
The round also included Lux Capital, GingerBread Capital, Blue Cross, Blue Shield Venture Partners, and actor Rob Lowe.
The company plans to use the funds to continue to expand operations and its business reach.
“The demand for telemedicine care accelerated with COVID-19, but providing quality addiction treatment to people in the privacy of their home has been our priority at Workit Health since day one,” said Robin McIntosh, Workit Health’s Co-Founder and Co-CEO.
“With Workit Health, it’s easier than ever before to take the first step towards recovery, and we’re excited to use this round of funding to bring our holistic and evidence-based care to more Americans.”
According to SAMHSA, only 1 in 10 people struggling with substance use disorder receive the care they need.
According to Workit Health, its telehealth programs combine evidence-based therapy with medication management from a clinical care team, resulting in better outcomes than traditional treatment programs. The personalized, medically-assisted treatment and nonjudgmental programs are accessible to people at all stages of addiction recovery.
“Our mission is to simplify treatment, but also to offer an improved experience,” said Lisa McLaughlin, Workit Health’s Co-Founder and Co-CEO. “We’re looking forward to working with Rob Lowe to raise awareness about the issue of addiction and help the country understand that expert support is just a click away.”
Telehealth companies around the world raised $3.3 billion in the first nine months of 2020, according to the latest Mercom digital health funding report. More recently, telehealth startup Sofia raised $19 million in a Series A funding round, bringing the company’s total to over $25 million to date.
